U.S. In-Vitro Diagnostic Substances Market. Analysis And Forecast to 2025
The report provides an in-depth analysis of the U.S. in-vitro diagnostic substance market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry.
In-vitro diagnostic substances
Abbott Diabetes Care, Orasure Technologies, Amag Pharmaceuticals, Streck, Diasorin Inc., Diadexus, Rapid Pathogen Screening, Maine Biotechnology Services, Saladax Biomedical, Corgenix Medical Corporation, George King Bio-Medical, Princeton Biomeditech Corp, Banyan Biomarkers, Anatech, Dxna LLC, CD Diagnostics, Akers Biosciences, Helica Biosystems, Green Mountain Antibodies, Biospacific, Innominata, Phase 2 Discovery, Immuno Concepts, Hepatochem, Lifecare Medical International, Horizon Diagnostic, Immucor Gti Diagnostics, Werfen USA, Ivd Intermediate Holdings B Inc., Opko Diagnostics, Horizon Diagnostic Inc, Immucor Gti Diagnostics, Werfen USA, Ivd Intermediate Holdings B Inc., Opko Diagnostics
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook